Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Real-world disease characteristics and frontline treatments used in chronic lymphocytic leukaemia in Bulgaria: An observational cohort study (DESCRIBE).

The Journal of international medical research - 1 Feb 2026

Graklanov Vasko, Radinoff Atanas, Micheva Ilina, Efraim Merlin Erol, Donchev Martin, Yankova Tanya, Slavcheva-Popova Vanya, Naneva Silvia, Hadjiev Evgueniy, Gercheva-Kyuchukova Liana, Petrova-Latkova Martina, Nikolov Ivan, Nenov Alexander, Ostojić Alen, Krasteva Stanislava, Grudeva-Popova Zhanet

Abstract excerpt

ObjectiveBruton tyrosine kinase inhibitors and B-cell lymphoma 2 inhibitors are currently the new standard active agents in chronic lymphocytic leukaemia. This observational study describes the real-world use of frontline treatment in Bulgarian patients with active chronic lymphocytic leukaemia and characterises the patient population receiving these treatments.MethodsDESCRIBE was a physician-chart review study...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Bulgaria

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cohort Studies

Share to Leukemia, Lymphocytic, Chronic, B-Cell

Share to Mutation

Share to Protein Kinase Inhibitors

Source

Open in PubMed Open full text

Identifiers

PMID: 41698655
DOI: 10.1177/03000605261421729
PMCID: PMC12909763

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Real-world disease characteristics and frontline treatments used in chronic lymphocytic leukaemia in Bulgaria: An observational cohort study (DESCRIBE).PMID 41698655Read ↗

Chronic lymphocytic leukemia treatment algorithm 2022.Semantic proximity Read ↗

COVID-19 severity in patients with chronic lymphocytic leukemia treated with venetoclax: a single-center observational cohort studySemantic proximity Read ↗

Chronic Lymphocytic Leukaemia in 2020: the Future Has Arrived.Semantic proximity Read ↗

Chronic lymphocytic leukemia in Oman: real-world outcomes, molecular testing gaps, and access to targeted therapy in a low- incidence settingSemantic proximity Read ↗

Factors influencing front line treatment of chronic lymphocytic leukemia: A French real-world study.Semantic proximity Read ↗

Are we finally getting personal? Moving towards a personalized approach in chronic lymphocytic leukemia.Semantic proximity Read ↗

Real-World Selection of Venetoclax-Obinutuzumab Versus BTK Inhibitor Therapy for Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.Semantic proximity Read ↗

Zanubrutinib and Venetoclax for Patients With Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma With and Without Del(17p)/TP53 Mutation: SEQUOIA Arm D Results.Semantic proximity Read ↗

Ibrutinib plus fludarabine, cyclophosphamide and rituximab (iFCR) as initial treatment in chronic lymphocytic leukemia/ small lymphocytic leukemia with or without TP53 aberrations: A prospective real-world study in Chinese cohortSemantic proximity Read ↗

Impact of Oral Targeted Therapy on the Economic Burden of Chronic Lymphocytic Leukemia in Canada.Semantic proximity Read ↗

Three-year cardiovascular and non-cardiovascular adverse events in patients with chronic lymphocytic leukemia or small cell lymphocytic lymphoma treated with Bruton tyrosine kinase inhibitors acalabrutinib or ibrutinib: a real-world analysisSemantic proximity Read ↗

Zanubrutinib: Coming of Age for BTK Inhibitors in the Treatment of Chronic Lymphocytic Leukemia?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.